TRIANGEL touts global medical laser platform across 80 countries

TRIANGEL says its medical laser platform is used in more than 80 countries and backed by FDA, CE, UKCA and ANVISA credentials. The company is positioning the system for aesthetics and surgery as distributors and clinics weigh certification, supply reliability and post-sale support.

Why it matters: - TRIANGEL is pitching a single medical laser platform for both aesthetics and surgery, a category where buyers care about regulatory clearance, clinical support and supply continuity. - The company says the platform is designed for cross-border procurement, where certification audits and long-term service access often determine whether clinics can buy and deploy equipment. - TRIANGEL is also using its global installation base to signal clinical credibility to physicians, distributors and hospital buyers.

What happened: - TRIANGEL, founded in 2013, is promoting its global medical laser platform for aesthetics and surgery. - The company says the platform is used in more than 80 countries and has more than 12,000 installed units. - TRIANGEL says more than 300 physicians, including aesthetic doctors, plastic surgeons and colorectal specialists, endorse its laser consoles. - The company points buyers to its official portal for technical specifications, clinical protocol documentation and factory quotations: More information.

The details: - TRIANGEL says it operates under ISO 13485:2016 quality management standards. - The platform carries FDA clearance, Medical CE certification under MDR, UKCA registration and ANVISA registration. - TRIANGEL says the CE work was audited by BSI 2797. - The company says its quality process includes optical component sourcing, cleanroom manufacturing and final testing. - TRIANGEL says a 12-person quality assurance team performs multi-stage inspections. - The company says each batch has Device History Record traceability, environmental particulate monitoring and biocompatibility evaluations for patient-contact optical accessories. - TRIANGEL says its clinical registry includes more than 15,000 successful surgical operations. - The company says those procedures were associated with minimal intraoperative bleeding and low post-procedure complication rates. - TRIANGEL says it works with 15 partner hospitals and four European clinical institutions on multi-center research. - The company says those collaborations support treatment parameters, tissue safety protocols and histological evaluation metrics. - TRIANGEL says its research and development team includes 20 optical, electrical and software engineers. - The company says its platforms use American QPC laser diode arrays built on gallium aluminum arsenide substrates. - TRIANGEL says the architecture is intended to deliver wavelength stability, controlled thermal emissions and low optical loss. - The product line includes the TR-B PLUS platform, which TRIANGEL says combines 980 nm and 1470 nm emission for scalpel-free facial and body lifting. - TRIANGEL says the TR-B PLUS results can last up to four years. - The ENDO PRO workstation combines interstitial lasers with 4 MHz fractional radiofrequency microneedling, according to the company. - TRIANGEL says its surgical portfolio also covers proctology, endovascular closure, percutaneous laser disc decompression, gynecology and ENT procedures. - The company says it runs two clinical training centers in the United States. - TRIANGEL says it has service branches in the United States, Italy and Portugal. - The company says it offers door-to-door delivery worldwide within two weeks. - TRIANGEL says it ships sterile optical fibers, cannula accessories and replacement handpieces from regional warehouses. - The company says direct factory sourcing can reduce intermediary markups and help distributors customize firmware, branding, casing and user interface language. - TRIANGEL says it provides technical documentation, clinical white papers, registration dossiers and marketing assets for distributor submissions and sales expansion.

Between the lines: - TRIANGEL is marketing more than hardware. The pitch centers on a full procurement package: certifications, training, service, documentation and logistics. - The emphasis on direct factory relationships suggests TRIANGEL is targeting distributors that want faster market entry and less dependence on third-party vendors. - The global footprint, if sustained, helps TRIANGEL compete on trust as much as on device performance.

What's next: - TRIANGEL is inviting medical aesthetic directors, plastic surgeons and equipment distributors to review the portfolio and request procurement quotations. - The company appears to be leaning on regulatory credentials and overseas support networks to expand further through clinics and distributors.